158 related articles for article (PubMed ID: 14513426)
21. BibA induces opsonizing antibodies conferring in vivo protection against group B Streptococcus.
Santi I; Maione D; Galeotti CL; Grandi G; Telford JL; Soriani M
J Infect Dis; 2009 Aug; 200(4):564-70. PubMed ID: 19586417
[TBL] [Abstract][Full Text] [Related]
22. Sword and shield: linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense.
Liu GY; Doran KS; Lawrence T; Turkson N; Puliti M; Tissi L; Nizet V
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14491-6. PubMed ID: 15381763
[TBL] [Abstract][Full Text] [Related]
23. Group B streptococcus induces trophoblast death.
Kaplan A; Chung K; Kocak H; Bertolotto C; Uh A; Hobel CJ; Simmons CF; Doran K; Liu GY; Equils O
Microb Pathog; 2008 Sep; 45(3):231-5. PubMed ID: 18599257
[TBL] [Abstract][Full Text] [Related]
24. Protein expression changes induced in murine peritoneal macrophages by Group B Streptococcus.
Susta F; Chiasserini D; Fettucciari K; Orvietani PL; Quotadamo F; Noce R; Bartoli A; Marconi P; Corazzi L; Binaglia L
Proteomics; 2010 Jun; 10(11):2099-112. PubMed ID: 20336680
[TBL] [Abstract][Full Text] [Related]
25. Group B streptococcal beta-hemolysin/cytolysin directly impairs cardiomyocyte viability and function.
Hensler ME; Miyamoto S; Nizet V
PLoS One; 2008 Jun; 3(6):e2446. PubMed ID: 18560574
[TBL] [Abstract][Full Text] [Related]
26. Characterization and virulence of hemolysin III from Vibrio vulnificus.
Chen YC; Chang MC; Chuang YC; Jeang CL
Curr Microbiol; 2004 Sep; 49(3):175-9. PubMed ID: 15386100
[TBL] [Abstract][Full Text] [Related]
27. Histopathologic changes in kidney and liver correlate with streptococcal pyrogenic exotoxin B production in the mouse model of group A streptococcal infection.
Kuo CF; Luo YH; Lin HY; Huang KJ; Wu JJ; Lei HY; Lin MT; Chuang WJ; Liu CC; Jin YT; Lin YS
Microb Pathog; 2004 May; 36(5):273-85. PubMed ID: 15043862
[TBL] [Abstract][Full Text] [Related]
28. Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci.
Draper DW; Bethea HN; He YW
Immunol Lett; 2006 Feb; 102(2):202-14. PubMed ID: 16242782
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic and molecular characterization of hyperpigmented group B Streptococci.
Lupo A; Ruppen C; Hemphill A; Spellerberg B; Sendi P
Int J Med Microbiol; 2014 Jul; 304(5-6):717-24. PubMed ID: 24933304
[TBL] [Abstract][Full Text] [Related]
30. Isogenic group B streptococci devoid of capsular polysaccharide or beta-hemolysin: pulmonary hemodynamic and gas exchange effects during bacteremia in piglets.
Gibson RL; Redding GJ; Truog WE; Henderson WR; Rubens CE
Pediatr Res; 1989 Sep; 26(3):241-5. PubMed ID: 2685736
[TBL] [Abstract][Full Text] [Related]
31. Identification and characterization of a two-component hemolysin from Edwardsiella ictaluri.
Williams ML; Lawrence ML
Vet Microbiol; 2005 Jul; 108(3-4):281-9. PubMed ID: 15923091
[TBL] [Abstract][Full Text] [Related]
32. The hemolytic and cytolytic activity of group B streptococcal hemolysin and its possible role in early onset group B streptococcal disease.
Tapsall JW; Phillips EA
Pathology; 1991 Apr; 23(2):139-44. PubMed ID: 1745564
[TBL] [Abstract][Full Text] [Related]
33. The role of group B streptococci beta-hemolysin expression in newborn lung injury.
Nizet V; Gibson RL; Rubens CE
Adv Exp Med Biol; 1997; 418():627-30. PubMed ID: 9331730
[TBL] [Abstract][Full Text] [Related]
34. The Streptococcus agalactiae Stringent Response Enhances Virulence and Persistence in Human Blood.
Hooven TA; Catomeris AJ; Bonakdar M; Tallon LJ; Santana-Cruz I; Ott S; Daugherty SC; Tettelin H; Ratner AJ
Infect Immun; 2018 Jan; 86(1):. PubMed ID: 29109175
[No Abstract] [Full Text] [Related]
35. Macrophage induced gelsolin in response to Group B Streptococcus (GBS) infection.
Fettucciari K; Ponsini P; Palumbo C; Rosati E; Mannucci R; Bianchini R; Modesti A; Marconi P
Cell Microbiol; 2015 Jan; 17(1):79-104. PubMed ID: 25130983
[TBL] [Abstract][Full Text] [Related]
36. Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages.
Segura MA; Cléroux P; Gottschalk M
FEMS Immunol Med Microbiol; 1998 Jul; 21(3):189-95. PubMed ID: 9718208
[TBL] [Abstract][Full Text] [Related]
37. β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection.
Kulkarni R; Randis TM; Antala S; Wang A; Amaral FE; Ratner AJ
PLoS One; 2013; 8(3):e59091. PubMed ID: 23505569
[TBL] [Abstract][Full Text] [Related]
38. Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins.
Persson E; Berg S; Bevanger L; Bergh K; Valsö-Lyng R; Trollfors B
Clin Microbiol Infect; 2008 Jan; 14(1):66-73. PubMed ID: 18034863
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of hemolysin expression during neonatal Streptococcus agalactiae sepsis.
Sigge A; Schmid M; Mauerer S; Spellerberg B
J Clin Microbiol; 2008 Feb; 46(2):807-9. PubMed ID: 18077645
[TBL] [Abstract][Full Text] [Related]
40. Group B Streptococcus β-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo.
Randis TM; Gelber SE; Hooven TA; Abellar RG; Akabas LH; Lewis EL; Walker LB; Byland LM; Nizet V; Ratner AJ
J Infect Dis; 2014 Jul; 210(2):265-73. PubMed ID: 24474814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
